These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 9479558
1. Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction. Fehmann HC, Bode HP, Ebert T, Karl A, Göke B. Horm Metab Res; 1997 Nov; 29(11):572-6. PubMed ID: 9479558 [Abstract] [Full Text] [Related]
2. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1. Delmeire D, Flamez D, Hinke SA, Cali JJ, Pipeleers D, Schuit F. Diabetologia; 2003 Oct; 46(10):1383-93. PubMed ID: 13680124 [Abstract] [Full Text] [Related]
3. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1. Green BD, Gault VA, Irwin N, Mooney MH, Bailey CJ, Harriott P, Greer B, Flatt PR, O'Harte FP. Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796 [Abstract] [Full Text] [Related]
4. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells. Salapatek AM, MacDonald PE, Gaisano HY, Wheeler MB. Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905 [Abstract] [Full Text] [Related]
5. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells. Fehmann HC, Jiang J, Pitt D, Schweinfurth J, Göke B. Pancreas; 1996 Oct; 13(3):273-82. PubMed ID: 8884849 [Abstract] [Full Text] [Related]
6. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line. Fehmann HC, Habener JF. FEBS Lett; 1991 Feb 25; 279(2):335-40. PubMed ID: 1672112 [Abstract] [Full Text] [Related]
7. Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: mechanisms of action. Montrose-Rafizadeh C, Egan JM, Roth J. Endocrinology; 1994 Aug 25; 135(2):589-94. PubMed ID: 8033807 [Abstract] [Full Text] [Related]
8. The effects of glucagon-like peptide-I (GLP-I) on hormone secretion from isolated human pancreatic islets. Fehmann HC, Hering BJ, Wolf MJ, Brandhorst H, Brandhorst D, Bretzel RG, Federlin K, Göke B. Pancreas; 1995 Aug 25; 11(2):196-200. PubMed ID: 7479679 [Abstract] [Full Text] [Related]
9. Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cells. Moens K, Berger V, Ahn JM, Van Schravendijk C, Hruby VJ, Pipeleers D, Schuit F. Diabetes; 2002 Mar 25; 51(3):669-75. PubMed ID: 11872665 [Abstract] [Full Text] [Related]
10. Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development. García-Flores M, Zueco JA, Alvarez E, Blázquez E. Eur J Biochem; 2001 Feb 25; 268(3):514-20. PubMed ID: 11168389 [Abstract] [Full Text] [Related]
11. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Parkes DG, Pittner R, Jodka C, Smith P, Young A. Metabolism; 2001 May 25; 50(5):583-9. PubMed ID: 11319721 [Abstract] [Full Text] [Related]
12. Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion. Pørksen N, Grøfte B, Nyholm B, Holst JJ, Pincus SM, Veldhuis JD, Schmitz O, Butler PC. Diabetes; 1998 Jan 25; 47(1):45-9. PubMed ID: 9421373 [Abstract] [Full Text] [Related]
13. Evidence that glucagon stimulates insulin secretion through its own receptor in rats. Kawai K, Yokota C, Ohashi S, Watanabe Y, Yamashita K. Diabetologia; 1995 Mar 25; 38(3):274-6. PubMed ID: 7758872 [Abstract] [Full Text] [Related]
14. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A. Bode HP, Moormann B, Dabew R, Göke B. Endocrinology; 1999 Sep 25; 140(9):3919-27. PubMed ID: 10465260 [Abstract] [Full Text] [Related]
15. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets. Laychock SG. Mol Cell Endocrinol; 1995 Aug 30; 113(1):19-28. PubMed ID: 8674810 [Abstract] [Full Text] [Related]
16. Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells. Fehmann HC, Janssen M, Göke B. Acta Diabetol; 1995 Oct 30; 32(3):176-81. PubMed ID: 8590787 [Abstract] [Full Text] [Related]
17. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent. Lam NT, Kieffer TJ. Minerva Endocrinol; 2002 Jun 30; 27(2):79-93. PubMed ID: 11961501 [Abstract] [Full Text] [Related]
18. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential. Gromada J, Brock B, Schmitz O, Rorsman P. Basic Clin Pharmacol Toxicol; 2004 Dec 30; 95(6):252-62. PubMed ID: 15569269 [Abstract] [Full Text] [Related]
19. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells. Miura Y, Matsui H. Am J Physiol Endocrinol Metab; 2003 Nov 30; 285(5):E1001-9. PubMed ID: 14534075 [Abstract] [Full Text] [Related]
20. Cooperative enhancement of insulinotropic action of GLP-1 by acetylcholine uncovers paradoxical inhibitory effect of beta cell muscarinic receptor activation on adenylate cyclase activity. Miguel JC, Abdel-Wahab YH, Green BD, Mathias PC, Flatt PR. Biochem Pharmacol; 2003 Jan 15; 65(2):283-92. PubMed ID: 12504804 [Abstract] [Full Text] [Related] Page: [Next] [New Search]